Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?
Authors:
- Klaudia StempaKSKlaudia Stempa
- Dominika WokołorczykDWDominika Wokołorczyk
- Wojciech KluźniakWKWojciech Kluźniak
- Emilia Rogoża-JaniszewskaEREmilia Rogoża-Janiszewska
- Karolina MalińskaKMKarolina Malińska
- Helena RudnickaHRHelena Rudnicka
- Tomasz HuzarskiTHTomasz Huzarski
- Jacek GronwaldJGJacek Gronwald
- Katarzyna GliniewiczKGKatarzyna Gliniewicz
- Tadeusz DębniakTDTadeusz Dębniak
- Anna JakubowskaAJAnna Jakubowska
- Marcin LenerMLMarcin Lener
Open Access
Abstract
The current cancer testing gene panels tend to be comprehensive rather than site-specific. BARD1 is one of the genes commonly included in the multi-cancer testing panels. Mutations in BARD1 confer an increase in the risk for breast cancer, but it is not studied whether or not they predispose to prostate cancer. To establish if BARD1 mutations also predispose to prostate cancer, we screened BARD1 in 390 Polish patients with hereditary prostate cancer. No truncating mutations were identified by sequencing. We also genotyped 5715 men with unselected prostate cancer, and 10,252 controls for three recurrent BARD1 variants, including p.Q564X, p.R658C and p.R659=. Neither variant conferred elevated risk of prostate cancer (ORs between 0.84 and 1.15, p-values between 0.57 and 0.93) nor did they influence prostate cancer characteristics or survival. We conclude that men with a BARD1 mutation are not at elevated prostate cancer risk. It is not justified to inform men about increased prostate cancer risk in case of identification of a BARD1 mutation. However, a female relative of a man with a BARD1 mutation may benefit from this information and be tested for the mutation, because BARD1 is a breast cancer susceptibility gene.Keywords
Funding Information
- National Science Centre Poland (2015/19/B/NZ2/02439)
This publication has 43 references indexed in Scilit:
- The genetic landscape of high-risk neuroblastomaNature Genetics, 2013
- Germline BRCA1 mutations increase prostate cancer riskBritish Journal of Cancer, 2012
- Germline Mutations inHOXB13and Prostate-Cancer RiskNew England Journal of Medicine, 2012
- Common variations in BARD1 influence susceptibility to high-risk neuroblastomaNature Genetics, 2009
- BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinaseOncogene, 2005
- Mutations in CHEK2 Associated with Prostate Cancer RiskThe American Journal of Human Genetics, 2003
- Cancer Incidence in BRCA1 Mutation CarriersJNCI: Journal of the National Cancer Institute, 2002
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Identification of a RING protein that can interact in vivo with the BRCA1 gene productNature Genetics, 1996
- Mendelian inheritance of familial prostate cancer.Proceedings of the National Academy of Sciences, 1992